Track Your Future Recoveries Withsnaptrade iconConnect Account

Teva Pharmaceutical Industries Ltd. Settlement
(NYSE: TEVA)
Settlement

Claim Deadline: May 17, 2022

Settlement Fund: $420,000,000

Settlement Class

All persons or entities that Purchasers and acquirers in domestic transactions of Teva Pharmaceutical Industries Ltd. (“Teva”) American Depositary Shares, Teva 7.00% mandatory convertible preferred shares, and/or certain Teva Pharmaceutical Finance Netherlands III B.V. (“Teva Finance”) U.S.-dollar-denominated senior notes during the period from February 6, 2014 through May 10, 2019, inclusive.

Important Documents

Settlement Status

Disbursed

Class Period

February 06, 2014 - February 16, 2022

Settlement Hearing Date

June 02, 2022

Opt-Out Deadline

May 02, 2022

Claims Admin

Epiq 
Epiq Class Action & Claims Solutions, Inc.In re Teva Securities LitigationP.O. Box 3565Portland, OR 97208-3565
+1 855-675-3124
info@TevaSecuritiesLitigation.com

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.